Theonie Anastassiadis is the founder of Alltrna. Alltrna has raised $159M in total funding. Latest round: Series B. Backed by Flagship Pioneering.
Theonie Anastassiadis is the Co-founder and Chief Innovation Officer at Alltrna, a Flagship Pioneering company. Alltrna is developing a transfer RNA (tRNA) platform to create therapeutics for genetic diseases caused by shared mutations. The company has raised $159 million, including a $50 million initial commitment and a $109 million Series B round led by Flagship.
Full founder directory · Investor directory · Company funding database · Fundraising library